Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent TaxesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amrep (AXR) Cash & Equivalents (2016 - 2026)

Amrep's Cash & Equivalents history spans 16 years, with the latest figure at $45.1 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 11.04% year-over-year to $45.1 million; the TTM value through Oct 2025 reached $45.1 million, up 11.04%, while the annual FY2025 figure was $39.5 million, 30.5% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $45.1 million at Amrep, down from $49.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $49.4 million in Q3 2025 and bottomed at $12.4 million in Q1 2023.
  • The 5-year median for Cash & Equivalents is $24.0 million (2021), against an average of $26.9 million.
  • The largest annual shift saw Cash & Equivalents crashed 57.5% in 2022 before it skyrocketed 142.97% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $30.3 million in 2021, then plummeted by 57.5% to $12.9 million in 2022, then increased by 29.74% to $16.7 million in 2023, then surged by 142.97% to $40.6 million in 2024, then grew by 11.04% to $45.1 million in 2025.
  • Per Business Quant, the three most recent readings for AXR's Cash & Equivalents are $45.1 million (Q4 2025), $49.4 million (Q3 2025), and $39.5 million (Q2 2025).